301015 百洋医药
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额22,917934,454813,850799,495305,754
投资活动产生之现金流量净额(187,937)(588,806)(732,319)(295,707)(117,326)
筹资活动产生之现金流量净额505,503365,4794,666(333,198)(543,585)
汇率变动对现金及现金等价物的影响(4,424)(9,730)2,2057205,870
现金及现金等价物净增加/(减少)336,059701,39688,403171,310(349,287)
期初现金及现金等价物余额1,923,9431,222,5461,134,143962,8341,142,680
期末现金及现金等价物余额2,260,0011,923,9431,222,5461,134,143793,393